Reklaw Management Co Inc is categorized under Blood Related Health Services in Houston, TX and active since 2001.
Reklaw Management Co Inc was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Blood Related Health Services business, which does work in the B2C market, and is classified as a Blood Related Health Services, under code number 621991 by the NAICS.
If you are seeking more information, feel free to contact Emory E Treadaway at the company’s single location by writing to 2001 Kirby Drive # 950, Houston, Texas TX 77019 or by phoning (713) 522-2733. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Reklaw Management Co Inc |
| Contact Person: | Emory E Treadaway |
| Address: | 2001 Kirby Drive # 950, Houston, Texas 77019 |
| Phone Number: | (713) 522-2733 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Blood Related Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 621991 |
| Share This Business: |
Reklaw Management Co Inc was started in 2001 to provide professional Blood Related Health Services under the SIC code 8099 and NAICS code 621991. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Emory E Treadaway for inquiries that concern Reklaw Management Co Inc by calling the company number (713) 522-2733, as your correspondence is most welcome. Additionally, the physical location of the single location of Reklaw Management Co Inc can be found at the coordinates 29.748244,-95.418671 as well as the street address 2001 Kirby Drive # 950 in Houston, Texas 77019.
For its online presence, you may visit Reklaw Management Co Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.